NO20002777L - FremgangsmÕte for bekjempelse av fedme - Google Patents
FremgangsmÕte for bekjempelse av fedmeInfo
- Publication number
- NO20002777L NO20002777L NO20002777A NO20002777A NO20002777L NO 20002777 L NO20002777 L NO 20002777L NO 20002777 A NO20002777 A NO 20002777A NO 20002777 A NO20002777 A NO 20002777A NO 20002777 L NO20002777 L NO 20002777L
- Authority
- NO
- Norway
- Prior art keywords
- obesity
- procedure
- combating obesity
- treated
- diseases
- Prior art date
Links
- 208000008589 Obesity Diseases 0.000 title abstract 3
- 235000020824 obesity Nutrition 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 229940118365 Endothelin receptor antagonist Drugs 0.000 abstract 1
- 201000005569 Gout Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 208000020832 chronic kidney disease Diseases 0.000 abstract 1
- 208000022831 chronic renal failure syndrome Diseases 0.000 abstract 1
- 239000002308 endothelin receptor antagonist Substances 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19754082A DE19754082A1 (de) | 1997-12-05 | 1997-12-05 | Methode zur Bekämpfung der Fettleibigkeit |
| PCT/EP1998/007501 WO1999029308A2 (de) | 1997-12-05 | 1998-11-21 | Methode zur bekämpfung der fettleibigkeit |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20002777D0 NO20002777D0 (no) | 2000-05-30 |
| NO20002777L true NO20002777L (no) | 2000-06-02 |
| NO324694B1 NO324694B1 (no) | 2007-12-03 |
Family
ID=7850913
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20002777A NO324694B1 (no) | 1997-12-05 | 2000-05-30 | Anvendelse av endotelinreseptor-antagonister for fremstilling av medikamenter for a kontrollere hyperlipidemi. |
| NO20074419A NO20074419L (no) | 1997-12-05 | 2007-08-30 | Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20074419A NO20074419L (no) | 1997-12-05 | 2007-08-30 | Anvendelse av endotelinreseptorantagonister for fremstilling av medikamenter for a bekjempe sykdom |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6197780B1 (no) |
| EP (1) | EP1035851B1 (no) |
| JP (1) | JP2002512173A (no) |
| KR (1) | KR20010032779A (no) |
| CN (1) | CN1152685C (no) |
| AT (1) | ATE204172T1 (no) |
| AU (1) | AU751053B2 (no) |
| BR (1) | BR9815335A (no) |
| CA (1) | CA2311423C (no) |
| CZ (1) | CZ300442B6 (no) |
| DE (2) | DE19754082A1 (no) |
| ES (1) | ES2162493T3 (no) |
| HU (1) | HUP0100171A3 (no) |
| NO (2) | NO324694B1 (no) |
| RU (1) | RU2292891C2 (no) |
| WO (1) | WO1999029308A2 (no) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| EP1130027A1 (de) * | 2000-02-29 | 2001-09-05 | Aventis Pharma Deutschland GmbH | Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben |
| US20050175667A1 (en) * | 2004-02-10 | 2005-08-11 | Wenda Carlyle | Use of endothelin antagonists to prevent restenosis |
| CA2904447C (en) | 2007-08-22 | 2017-01-03 | Abbvie Deutschland Gmbh & Co Kg | Therapy for complications of diabetes |
| DK2776038T3 (en) | 2011-11-11 | 2018-04-23 | Gilead Apollo Llc | ACC INHIBITORS AND APPLICATIONS THEREOF |
| EA201700155A1 (ru) * | 2014-10-20 | 2017-10-31 | Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" | Фармацевтическая композиция для лечения туберкулеза |
| AR106472A1 (es) | 2015-10-26 | 2018-01-17 | Gilead Apollo Llc | Inhibidores de acc y usos de los mismos |
| PT3380479T (pt) | 2015-11-25 | 2023-03-13 | Gilead Apollo Llc | Inhibidores de triazol acc e seus usos |
| US20170166582A1 (en) | 2015-11-25 | 2017-06-15 | Gilead Apollo, Llc | Pyrazole acc inhibitors and uses thereof |
| US20170166583A1 (en) | 2015-11-25 | 2017-06-15 | Gilead Apollo, Llc | Ester acc inhibitors and uses thereof |
| US20170166585A1 (en) | 2015-11-25 | 2017-06-15 | Gilead Apollo, Llc | Pesticidal compositions and uses thereof |
| CN112920200A (zh) | 2016-03-02 | 2021-06-08 | 吉利德阿波罗公司 | 噻吩并嘧啶二酮acc抑制剂的固体形式及其制备方法 |
| JP6906626B2 (ja) | 2017-03-28 | 2021-07-21 | ギリアード サイエンシーズ， インコーポレイテッド | 肝疾患を処置するための治療的組み合わせ |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR950704314A (ko) | 1992-12-01 | 1995-11-17 | 가와노 다케히코 | 1,8-나프티리딘-2-온 유도체 및 그 사용 방법(1,8-naphthyridin-2-one derivative and use thereof) |
| AU6603996A (en) * | 1995-08-24 | 1997-03-19 | Warner-Lambert Company | Furanone endothelin antagonists |
| JP3116347B2 (ja) * | 1996-11-13 | 2000-12-11 | 田辺製薬株式会社 | 医薬組成物 |
-
1997
- 1997-12-05 DE DE19754082A patent/DE19754082A1/de not_active Withdrawn
-
1998
- 1998-11-21 DE DE59801230T patent/DE59801230D1/de not_active Expired - Lifetime
- 1998-11-21 US US09/530,131 patent/US6197780B1/en not_active Expired - Lifetime
- 1998-11-21 EP EP98965685A patent/EP1035851B1/de not_active Expired - Lifetime
- 1998-11-21 CN CNB988118327A patent/CN1152685C/zh not_active Expired - Fee Related
- 1998-11-21 KR KR1020007006075A patent/KR20010032779A/ko not_active Ceased
- 1998-11-21 AT AT98965685T patent/ATE204172T1/de active
- 1998-11-21 AU AU21535/99A patent/AU751053B2/en not_active Ceased
- 1998-11-21 CA CA002311423A patent/CA2311423C/en not_active Expired - Fee Related
- 1998-11-21 CZ CZ20002006A patent/CZ300442B6/cs not_active IP Right Cessation
- 1998-11-21 HU HU0100171A patent/HUP0100171A3/hu unknown
- 1998-11-21 WO PCT/EP1998/007501 patent/WO1999029308A2/de not_active Ceased
- 1998-11-21 ES ES98965685T patent/ES2162493T3/es not_active Expired - Lifetime
- 1998-11-21 JP JP2000523980A patent/JP2002512173A/ja active Pending
- 1998-11-21 BR BR9815335-8A patent/BR9815335A/pt not_active Application Discontinuation
-
2000
- 2000-05-30 NO NO20002777A patent/NO324694B1/no not_active IP Right Cessation
-
2003
- 2003-12-29 RU RU2003138080/15A patent/RU2292891C2/ru not_active IP Right Cessation
-
2007
- 2007-08-30 NO NO20074419A patent/NO20074419L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999029308A3 (de) | 1999-09-30 |
| NO20002777D0 (no) | 2000-05-30 |
| JP2002512173A (ja) | 2002-04-23 |
| DE19754082A1 (de) | 1999-06-10 |
| BR9815335A (pt) | 2000-10-17 |
| NO324694B1 (no) | 2007-12-03 |
| ATE204172T1 (de) | 2001-09-15 |
| HK1037141A1 (en) | 2002-02-01 |
| WO1999029308A2 (de) | 1999-06-17 |
| DE59801230D1 (de) | 2001-09-20 |
| CN1152685C (zh) | 2004-06-09 |
| EP1035851B1 (de) | 2001-08-16 |
| CN1301162A (zh) | 2001-06-27 |
| EP1035851A2 (de) | 2000-09-20 |
| KR20010032779A (ko) | 2001-04-25 |
| NO20074419L (no) | 2000-06-02 |
| ES2162493T3 (es) | 2001-12-16 |
| AU751053B2 (en) | 2002-08-08 |
| AU2153599A (en) | 1999-06-28 |
| CA2311423A1 (en) | 1999-06-17 |
| HUP0100171A3 (en) | 2003-10-28 |
| HUP0100171A2 (hu) | 2003-02-28 |
| CZ20002006A3 (cs) | 2000-11-15 |
| RU2003138080A (ru) | 2005-06-10 |
| RU2292891C2 (ru) | 2007-02-10 |
| US6197780B1 (en) | 2001-03-06 |
| CA2311423C (en) | 2008-01-29 |
| CZ300442B6 (cs) | 2009-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20002777L (no) | FremgangsmÕte for bekjempelse av fedme | |
| DK1047781T3 (da) | IL-18-receptorer | |
| ES2184127T3 (es) | Derivados de sulfamato anticonvulsivos utiles para el tratamiento de la obesidad. | |
| EP1231218A3 (en) | An appetite-suppressing peptide, its compositions and use | |
| DE69732868D1 (de) | Mittel gegen Juckreiz | |
| DK1119371T3 (da) | Flt4 (VEGFR-3) som et mål for tumorbilleddannelse og antitumorterapi | |
| EE9800171A (et) | 3-pürasoolkarboksamiidi derivaadid, mis omavad afiinsust kannabinoidretseptori suhtes | |
| CY1107829T1 (el) | Νεες ενωσεις αγωνιστες εξεντινης | |
| FI920217L (fi) | Angiotensin ii receptor blockerande 2,3,6-substituerade kinazolinoner. | |
| TR970073A2 (tr) | Alfa adrenerjik resentör antagonistleri olarak pirimidindion pirimidintrion,triazindion, tetrahidrokinazolindion türevleri. | |
| DK1094816T3 (da) | Biphenylsulfonamider som dobbelte angiotensin-endothelin-receptorantagonister | |
| CL2010000375A1 (es) | Compuestos mimeticos de glucocorticoides derivados de hidroxialquilo sustituidos por heterociclos; procedimiento de preparacion; composicion farmaceutica; kit farmaceutico; y uso para el tratamiento de un estado o trastorno seleccionado de diabetes tipo ii, obesidad, hipertension, entre otras (divisional de solicitud 585-03). | |
| MX225999B (es) | Polimorfo antifungico cristalino. | |
| ATE268750T1 (de) | Proteintyrosinphosphatase inhibitoren | |
| DE60041185D1 (de) | Krebsbehandlung mit antagonisten des endothelinrezeptors | |
| EP0684823A4 (en) | FIBRINOGEN RECEPTOR ANTAGONISTS. | |
| TR200001290T2 (tr) | Estrojen mahrumiyet sendromunu tedavi etmek için yararlı 2-aril-3-aroilbenzo(b) tiofenler. | |
| EP1090994A3 (en) | Peptide repeat immunogens | |
| DE59604033D1 (de) | Grossformatiger Schamottestein, insbesondere Zinnbadbodenstein | |
| RU2000117857A (ru) | Способ борьбы с ожирением | |
| FR2718727B1 (fr) | Carbure de tungstène non steochiométrique. | |
| BR1100506A (pt) | Composição para o tratamento de um ser humano sofrendo de um distúrbio intestinal. | |
| ES1035823U (es) | Bovedilla perfeccionada. | |
| TR199601082A3 (tr) | Entegrin reseptör antagonistleri. | |
| IT239289Y1 (it) | Lumino per sepolcri, immagini votive e simili. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CHAD | Change of the owner's name or address (par. 44 patent law, par. patentforskriften) |
Owner name: ABBVIE DEUTSCHLAND GMBH & CO AG, DE |
|
| MM1K | Lapsed by not paying the annual fees |